Digital Therapeutics Global Market Report 2022: Growing Research Activities, and the Increasing Use of Smartphones, mHealth Apps, and Wearables in Medicine Drives Growth
November 24, 2022 06:38 ET
|
Research and Markets
Dublin, Nov. 24, 2022 (GLOBE NEWSWIRE) -- The "Digital Therapeutics: A New Age Medicine" report has been added to ResearchAndMarkets.com's offering. Digital therapeutics (DTx) is considered a...
Digital Medicine Market Emerging Size, Consumer-Demands [2022-2030] | Future Innovations, Latest Technology, Industry Revenue, Sales Value & Volume, Development and Dynamics, Key Raw Materials, Economic Factors, New Entrants Till 2030
September 27, 2022 02:24 ET
|
Industry Research
Pune, Sept. 27, 2022 (GLOBE NEWSWIRE) -- Global “Digital Medicine Market” 2016-2030 report discovers comprehensive insights on key manufacturers with share information, market size and projection,...
United States Digital Therapeutics Market Analysis Report 2022-2027: Entry of Several Start-ups and Rapid Surge in Funding & Investments for DTx Companies
July 19, 2022 07:13 ET
|
Research and Markets
Dublin, July 19, 2022 (GLOBE NEWSWIRE) -- The "U.S. Digital Therapeutics Market - Industry Outlook and Forecast 2022-2027" report has been added to ResearchAndMarkets.com's offering.Digital...
$55 Billion Global Internet of Medical Things Market Expected to Grow at a CAGR of 24.55% Between 2021 and 2026
January 28, 2022 04:43 ET
|
Research and Markets
Dublin, Jan. 28, 2022 (GLOBE NEWSWIRE) -- The "Internet of Medical Things (IoMT) Market - Forecasts from 2021 to 2026" report has been added to ResearchAndMarkets.com's offering. The global Internet...
USA Equities Corp. Announces Third Quarter 2021 Financial Results And Conversion of Secured Convertible Promissory Note
November 16, 2021 07:30 ET
|
USA Equities Corp
● Revenue Surpassed $1 million for Nine Months of 2021 Compared to $0 for the Same Period 2020 ● Gross Margin of 48% in Q3 Increased 290 Basis Points Versus Q2 2021 ● Issuance of 76,923 Shares...
USA Equities Corp. Announces Strong Second Quarter 2021 Results
August 17, 2021 08:30 ET
|
USA Equities Corp
Second Quarter 2021 Financial Results In-Line with July Pre-AnnouncementSuccessful $750,000 Capital Raise Increases Financial Flexibility to Execute on Growth StrategyAcquired AllergiEnd® Assets...
USA Equities Corp. Announces Strong Second Quarter 2021 Financial Results
July 15, 2021 07:30 ET
|
USA Equities Corp
● Revenue Grew 50% to $456,219 Compared to Q1 2021 ● Gross Margin of 46% Increased 164 Basis Points Versus Q1 2021 ● Strengthening of Company Financial Position and Strategic Relationships West Palm...
USA Equities Corp Announces the Signing of a Distribution Agreement with a Prominent Physician Management Services Firm For its AllergiEnd® Products and Services
June 29, 2021 07:30 ET
|
USA Equities Corp
-Continued Momentum Expanding Independent Care Practitioner Network- West Palm Beach, FL, June 29, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on value-based...
USA Equities Corp. Acquires AllergiEnd®Assets
June 24, 2021 07:00 ET
|
USA Equities Corp
●Acquisition Strengthens USAQ Business Model and Strategic Position●Purchase includes AllergiEnd® Method Patent, Trademark and Website●AllergiEnd®’s Product Portfolio Favorably Aligned with Industry...
USA Equities Corp Announces Co-Promotion Agreement with ENP Network for AllergiEnd® and Upcoming University of Miami CME Workshop
June 09, 2021 08:00 ET
|
USA Equities Corp
-Further Expanding Independent Practitioner Network and Industry Visibility- West Palm Beach, FL, June 09, 2021 (GLOBE NEWSWIRE) -- USA Equities Corp. (OTCQB: USAQ), a company focused on...